| Literature DB >> 1775116 |
Abstract
Clinically significant medication-nutrient interactions are of concern to the nutritional support practitioner. To emphasize the possible effect of the aluminum-containing medication sucralfate on serum phosphorus levels, patients admitted to the intensive care unit of a small private hospital were monitored for a 4-week period. Sixteen patients demonstrated low serum phosphorus levels; eight (50%) of these were receiving sucralfate. Eighteen patients had no low phosphorus levels measured; five (28%) patients in this group were receiving sucralfate. The hypophosphatemia observed in these patients was probably multifactorial; respiratory alkalosis and dextrose feeding as well as sucralfate use are consistent with hypophosphatemia.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1775116 DOI: 10.1177/0115426591006005199
Source DB: PubMed Journal: Nutr Clin Pract ISSN: 0884-5336 Impact factor: 3.080